BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5868718)

  • 1. [Survival time of type A 3 donor erythrocytes in an O recipient].
    Jensen KG; Sorensen SS
    Ugeskr Laeger; 1965 Sep; 127(38):1204-5. PubMed ID: 5868718
    [No Abstract]   [Full Text] [Related]  

  • 2. [Survival time of "posthemorrhagic" homologous erythrocytes in healthy dogs].
    Gorbunova NA; Garfunkel' ML
    Patol Fiziol Eksp Ter; 1974; (1):14-7. PubMed ID: 4459779
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver transplantation in Diego blood disparity: a case report.
    Sawada T; Kubota K; Kita J; Furihata T; Iso Y; Kato M; Rokkaku K; Shimoda M
    Transplantation; 2007 Feb; 83(4):510-3. PubMed ID: 17318085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood--a whole special juice].
    Dingermann T; Zündorf I
    Pharm Unserer Zeit; 2007; 36(4):250. PubMed ID: 17623311
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization.
    Senzel L; Boulad F; Wuest D; Reid ME
    Transfusion; 2007 May; 47(5):781-7. PubMed ID: 17465941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythrocytes in tissue and immune homeostasis].
    Ol'shanskiĭ AIa; Odinokova VA; Kvitko NN
    Sov Med; 1984; (11):43-8. PubMed ID: 6395357
    [No Abstract]   [Full Text] [Related]  

  • 7. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.
    Bourge RC; Naftel DC; Costanzo-Nordin MR; Kirklin JK; Young JB; Kubo SH; Olivari MT; Kasper EK
    J Heart Lung Transplant; 1993; 12(4):549-62. PubMed ID: 8369318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of erythrocytes after autologous and allogeneic transfusion in cats.
    Marion RS; Smith JE
    J Am Vet Med Assoc; 1983 Dec; 183(12):1437-9. PubMed ID: 6654723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes mellitus on transplantation.
    Waki K
    Clin Transpl; 2004; ():357-77. PubMed ID: 16704163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient.
    Markiewicz M; Wojnar J; Giebel S; Wieczorkiewicz A; Wylezoł I; Hołowiecki J
    Bone Marrow Transplant; 2006 Feb; 37(4):433-4. PubMed ID: 16400335
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed erythrocyte chimerism: implications for tolerance of the donor immune system to recipient non-ABO system red cell antigens.
    Wennerberg A; Backman KA; Gillerlain C; Robertson V; Jones C; Joyner T
    Bone Marrow Transplant; 1996 Aug; 18(2):433-5. PubMed ID: 8864458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into A antigen expression on O2 heterozygous group O-labeled red blood cell units.
    Yazer MH; Hult AK; Hellberg A; Hosseini-Maaf B; Palcic MM; Olsson ML
    Transfusion; 2008 Aug; 48(8):1650-7. PubMed ID: 18482182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors on graft survival of living donor kidney transplantation in a single center.
    Jin DC; Yoon YS; Kim YS; Yoon SA; Ahn SJ; Kim SY; Chang YS; Bang BK; Koh YB
    Clin Transplant; 1996 Dec; 10(6 Pt 1):471-7. PubMed ID: 8996765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to optimize PEG-coating of red blood cells.
    Hashemi-Najafabadi S; Vasheghani-Farahani E; Shojaosadati SA; Rasaee MJ; Armstrong JK; Moin M; Pourpak Z
    Bioconjug Chem; 2006; 17(5):1288-93. PubMed ID: 16984140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between immunoperoxidase methods and the erythrocyte adherence test in the evaluation of iso-antigens of blood groups in the normal, hyperplastic and neoplastic urothelium].
    Zanella L; Mattarozzi A; Bacchini P; Bertoni F
    Pathologica; 1984; 76(1043):347-57. PubMed ID: 6387602
    [No Abstract]   [Full Text] [Related]  

  • 17. Inappropriate expression of blood group antigens in hepatic allografts.
    Bloom S; Fleming K; Chapman R; Neuberger J; Hubscher S
    Hepatology; 1994 Apr; 19(4):876-81. PubMed ID: 8138260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?
    Lerut E; Van Damme B; Noizat-Pirenne F; Emonds MP; Rouger P; Vanrenterghem Y; Pirenne J; Ansart-Pirenne H
    Transfusion; 2007 Jan; 47(1):28-40. PubMed ID: 17207227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.
    Zupańska B; Zaucha JM; Michalewska B; Malinowska A; Brojer E; Hellmann A
    Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational issues for implementation of donor genotyping for red blood cell antigens.
    Nance ST
    Transfusion; 2007 Jul; 47(1 Suppl):69S-72S. PubMed ID: 17593290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.